Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development

The spike protein of coronavirus is key target for drug development and other pharmacological interventions. In current study, we performed an integrative approach to predict antigenic sites in SARS-CoV-2 spike receptor binding domain and found nine potential antigenic sites. The predicted antigenic...

Descripción completa

Detalles Bibliográficos
Autor principal: Dakal, Tikam Chand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297981/
https://www.ncbi.nlm.nih.gov/pubmed/34303920
http://dx.doi.org/10.1016/j.imbio.2021.152091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297981/
https://www.ncbi.nlm.nih.gov/pubmed/34303920
http://dx.doi.org/10.1016/j.imbio.2021.152091

Ejemplares similares